Pfizer names new vice president of medical affairs for oncology unit

In this role, Dr George will be responsible for managing external relationships with cancer agencies, organizations and specialists around the world. Most recently, Dr George held the position of senior vice president of drug development and chief medical officer at GPC Biotech.

Dr George has received her MSc in pharmacology from Montreal University in 1973, her MD from Paris University in 1975, and is board certified in medical oncology.

Mace Rothenberg, senior vice president of clinical development and medical affairs for oncology business unit at Pfizer, said: “We are delighted that Dr George – with her impressive record as a leader in global pharmaceutical organizations – will be joining Pfizer’s oncology business unit and look forward to her contributions in advancing science needed to bring innovative medicines to patients.”